

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | histone H3-K4 methylation (GO:0051568) | 4.49307263 |
| 2 | histone H3-K4 trimethylation (GO:0080182) | 4.42205301 |
| 3 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.32599364 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.02791023 |
| 5 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.02586377 |
| 6 | negative regulation of granulocyte differentiation (GO:0030853) | 3.93586592 |
| 7 | regulation of granulocyte differentiation (GO:0030852) | 3.77294416 |
| 8 | positive regulation of granulocyte differentiation (GO:0030854) | 3.76193667 |
| 9 | negative regulation of cAMP-mediated signaling (GO:0043951) | 3.67921829 |
| 10 | detection of bacterium (GO:0016045) | 3.64351357 |
| 11 | mannose metabolic process (GO:0006013) | 3.56764596 |
| 12 | regulation of gamma-delta T cell activation (GO:0046643) | 3.49996219 |
| 13 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 3.48979877 |
| 14 | detection of other organism (GO:0098543) | 3.44720569 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.42159567 |
| 16 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.39126990 |
| 17 | regulation of B cell apoptotic process (GO:0002902) | 3.36315200 |
| 18 | response to lipoprotein particle (GO:0055094) | 3.33191487 |
| 19 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.30796022 |
| 20 | response to peptidoglycan (GO:0032494) | 3.28849928 |
| 21 | dosage compensation (GO:0007549) | 3.22690034 |
| 22 | diaphragm development (GO:0060539) | 3.18524405 |
| 23 | pyrimidine nucleoside salvage (GO:0043097) | 3.13871390 |
| 24 | pyrimidine-containing compound salvage (GO:0008655) | 3.13871390 |
| 25 | histone H3-K36 demethylation (GO:0070544) | 3.12910150 |
| 26 | exogenous drug catabolic process (GO:0042738) | 3.12747309 |
| 27 | B cell receptor signaling pathway (GO:0050853) | 3.12188799 |
| 28 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.10827943 |
| 29 | cellular response to ethanol (GO:0071361) | 3.08434163 |
| 30 | drug catabolic process (GO:0042737) | 3.01238992 |
| 31 | detection of biotic stimulus (GO:0009595) | 3.00144322 |
| 32 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.98885516 |
| 33 | peptidyl-lysine trimethylation (GO:0018023) | 2.98571963 |
| 34 | regulation of mRNA catabolic process (GO:0061013) | 2.92265367 |
| 35 | arginine catabolic process (GO:0006527) | 2.90008844 |
| 36 | positive regulation of protein homooligomerization (GO:0032464) | 2.86249238 |
| 37 | detection of external biotic stimulus (GO:0098581) | 2.84093356 |
| 38 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.83833841 |
| 39 | L-phenylalanine catabolic process (GO:0006559) | 2.83833841 |
| 40 | histone demethylation (GO:0016577) | 2.82356878 |
| 41 | positive regulation of Rap GTPase activity (GO:0032854) | 2.80902333 |
| 42 | regulation of mitochondrial translation (GO:0070129) | 2.79892054 |
| 43 | protein demethylation (GO:0006482) | 2.78823737 |
| 44 | protein dealkylation (GO:0008214) | 2.78823737 |
| 45 | positive regulation of B cell differentiation (GO:0045579) | 2.78483406 |
| 46 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.77413610 |
| 47 | histone H3-K9 demethylation (GO:0033169) | 2.75424825 |
| 48 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.74162027 |
| 49 | positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145) | 2.73312010 |
| 50 | negative regulation of interleukin-12 production (GO:0032695) | 2.73032933 |
| 51 | histone H4-K16 acetylation (GO:0043984) | 2.72355871 |
| 52 | negative regulation of protein oligomerization (GO:0032460) | 2.72335400 |
| 53 | histone lysine methylation (GO:0034968) | 2.72191544 |
| 54 | histone lysine demethylation (GO:0070076) | 2.70437201 |
| 55 | negative regulation of innate immune response (GO:0045824) | 2.69472478 |
| 56 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.69045521 |
| 57 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.64875497 |
| 58 | toxin transport (GO:1901998) | 2.64722371 |
| 59 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.64620700 |
| 60 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.64103924 |
| 61 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.62805578 |
| 62 | RNA destabilization (GO:0050779) | 2.62769456 |
| 63 | histone H3-K9 modification (GO:0061647) | 2.62259524 |
| 64 | response to host (GO:0075136) | 2.61393383 |
| 65 | response to host defenses (GO:0052200) | 2.61393383 |
| 66 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61393383 |
| 67 | positive regulation of mRNA catabolic process (GO:0061014) | 2.60934374 |
| 68 | response to host immune response (GO:0052572) | 2.60789761 |
| 69 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.60789761 |
| 70 | negative regulation of bone resorption (GO:0045779) | 2.58816338 |
| 71 | histone H4-K8 acetylation (GO:0043982) | 2.57777966 |
| 72 | histone H4-K5 acetylation (GO:0043981) | 2.57777966 |
| 73 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.55874019 |
| 74 | negative thymic T cell selection (GO:0045060) | 2.55516328 |
| 75 | nitric oxide mediated signal transduction (GO:0007263) | 2.55429513 |
| 76 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.53970025 |
| 77 | TOR signaling (GO:0031929) | 2.53770778 |
| 78 | establishment of protein localization to Golgi (GO:0072600) | 2.53585525 |
| 79 | negative regulation of cell size (GO:0045792) | 2.53360660 |
| 80 | macrophage activation involved in immune response (GO:0002281) | 2.51379012 |
| 81 | germinal center formation (GO:0002467) | 2.48939250 |
| 82 | regulation of monocyte differentiation (GO:0045655) | 2.48385405 |
| 83 | regulation of energy homeostasis (GO:2000505) | 2.48264632 |
| 84 | negative regulation of interleukin-6 production (GO:0032715) | 2.45368662 |
| 85 | peptidyl-lysine methylation (GO:0018022) | 2.45291404 |
| 86 | protein targeting to Golgi (GO:0000042) | 2.44018574 |
| 87 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.43915985 |
| 88 | L-phenylalanine metabolic process (GO:0006558) | 2.43915985 |
| 89 | actin nucleation (GO:0045010) | 2.43579974 |
| 90 | skeletal muscle organ development (GO:0060538) | 2.41476758 |
| 91 | response to muramyl dipeptide (GO:0032495) | 2.41279445 |
| 92 | N-acetylneuraminate metabolic process (GO:0006054) | 2.41006375 |
| 93 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.40830250 |
| 94 | positive regulation by symbiont of host defense response (GO:0052509) | 2.39756018 |
| 95 | modulation by symbiont of host defense response (GO:0052031) | 2.39756018 |
| 96 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.39756018 |
| 97 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.39756018 |
| 98 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.39756018 |
| 99 | modulation by symbiont of host immune response (GO:0052553) | 2.39756018 |
| 100 | respiratory chain complex IV assembly (GO:0008535) | 2.38993526 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.35551404 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.33151544 |
| 3 | MYC_22102868_ChIP-Seq_BL_Human | 3.25890366 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.11731993 |
| 5 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.49988886 |
| 6 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.43711818 |
| 7 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.41596963 |
| 8 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.39400552 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.35721628 |
| 10 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.26307731 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.22633888 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.16786889 |
| 13 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.16417592 |
| 14 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.11391830 |
| 15 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.10067998 |
| 16 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.04834384 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.99504317 |
| 18 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96648421 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 1.94182444 |
| 20 | UTX_26944678_Chip-Seq_JUKART_Human | 1.91087047 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 1.89766342 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86501484 |
| 23 | * MAF_26560356_Chip-Seq_TH1_Human | 1.85354376 |
| 24 | * KDM5A_27292631_Chip-Seq_BREAST_Human | 1.83372409 |
| 25 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.82887508 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80827535 |
| 27 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.78847414 |
| 28 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.77774602 |
| 29 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.75928702 |
| 30 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75584395 |
| 31 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.71566650 |
| 32 | SPI1_23127762_ChIP-Seq_K562_Human | 1.71234658 |
| 33 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.70925190 |
| 34 | MYB_26560356_Chip-Seq_TH1_Human | 1.70435411 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.70142409 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69182768 |
| 37 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.68259391 |
| 38 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67331030 |
| 39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.65607735 |
| 40 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63022359 |
| 41 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61732586 |
| 42 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.60672342 |
| 43 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.59536089 |
| 44 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59522008 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.58182743 |
| 46 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.56808047 |
| 47 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.54810367 |
| 48 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.54382572 |
| 49 | P68_20966046_ChIP-Seq_HELA_Human | 1.51452909 |
| 50 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50092886 |
| 51 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.46735158 |
| 52 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46026157 |
| 53 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.45410885 |
| 54 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.44013686 |
| 55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.40751779 |
| 56 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.40537300 |
| 57 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.39393148 |
| 58 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.37694007 |
| 59 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37482044 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37077556 |
| 61 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36234283 |
| 62 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.35119391 |
| 63 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.33357248 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.32540323 |
| 65 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31144740 |
| 66 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.30553753 |
| 67 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.27721949 |
| 68 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27561992 |
| 69 | P300_27268052_Chip-Seq_Bcells_Human | 1.27491662 |
| 70 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26877391 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 1.26484523 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.26405896 |
| 73 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.26234820 |
| 74 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.25724877 |
| 75 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25199496 |
| 76 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.24759990 |
| 77 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24750846 |
| 78 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.22574380 |
| 79 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.22195963 |
| 80 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.19294687 |
| 81 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.19146052 |
| 82 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.17689874 |
| 83 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.15522985 |
| 84 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.14465156 |
| 85 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.13321037 |
| 86 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.10701729 |
| 87 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10361141 |
| 88 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.09460100 |
| 89 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08805504 |
| 90 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.07615620 |
| 91 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.07158297 |
| 92 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07149899 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.06010072 |
| 94 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.05822290 |
| 95 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.04498340 |
| 96 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04409501 |
| 97 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.02844122 |
| 98 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01259018 |
| 99 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.00858089 |
| 100 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.98943222 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003172_abnormal_lysosome_physiology | 2.96005441 |
| 2 | MP0009278_abnormal_bone_marrow | 2.65399839 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 2.57032334 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.39713319 |
| 5 | MP0002396_abnormal_hematopoietic_system | 2.38519824 |
| 6 | MP0003195_calcinosis | 2.37521509 |
| 7 | MP0003436_decreased_susceptibility_to | 2.31835264 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.23244659 |
| 9 | MP0004043_abnormal_pH_regulation | 2.19077820 |
| 10 | MP0003646_muscle_fatigue | 2.13960424 |
| 11 | MP0002132_abnormal_respiratory_system | 2.13485782 |
| 12 | MP0003303_peritoneal_inflammation | 2.09643839 |
| 13 | MP0002009_preneoplasia | 2.09028470 |
| 14 | MP0005058_abnormal_lysosome_morphology | 2.03617816 |
| 15 | MP0005645_abnormal_hypothalamus_physiol | 2.01293067 |
| 16 | MP0000685_abnormal_immune_system | 1.92025231 |
| 17 | MP0009840_abnormal_foam_cell | 1.88023093 |
| 18 | MP0005387_immune_system_phenotype | 1.83819130 |
| 19 | MP0001790_abnormal_immune_system | 1.83819130 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.82179551 |
| 21 | MP0001800_abnormal_humoral_immune | 1.77228732 |
| 22 | MP0001873_stomach_inflammation | 1.73389245 |
| 23 | MP0004808_abnormal_hematopoietic_stem | 1.73368439 |
| 24 | MP0002419_abnormal_innate_immunity | 1.71649155 |
| 25 | MP0005310_abnormal_salivary_gland | 1.69026390 |
| 26 | MP0008260_abnormal_autophagy | 1.67795676 |
| 27 | MP0006082_CNS_inflammation | 1.64485806 |
| 28 | MP0002693_abnormal_pancreas_physiology | 1.63901332 |
| 29 | MP0003300_gastrointestinal_ulcer | 1.59918093 |
| 30 | MP0002723_abnormal_immune_serum | 1.56430494 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.55678750 |
| 32 | MP0004233_abnormal_muscle_weight | 1.55378896 |
| 33 | MP0002405_respiratory_system_inflammati | 1.55016022 |
| 34 | MP0001764_abnormal_homeostasis | 1.54672840 |
| 35 | MP0001819_abnormal_immune_cell | 1.53430320 |
| 36 | MP0005025_abnormal_response_to | 1.53367727 |
| 37 | MP0003283_abnormal_digestive_organ | 1.52908377 |
| 38 | MP0002452_abnormal_antigen_presenting | 1.49028524 |
| 39 | MP0005000_abnormal_immune_tolerance | 1.48023037 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.42557646 |
| 41 | MP0002398_abnormal_bone_marrow | 1.41191642 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.36431868 |
| 43 | MP0001545_abnormal_hematopoietic_system | 1.35681251 |
| 44 | MP0005397_hematopoietic_system_phenotyp | 1.35681251 |
| 45 | MP0003045_fibrosis | 1.31592623 |
| 46 | MP0002166_altered_tumor_susceptibility | 1.31563356 |
| 47 | MP0003191_abnormal_cellular_cholesterol | 1.31170668 |
| 48 | MP0005464_abnormal_platelet_physiology | 1.30825642 |
| 49 | MP0003724_increased_susceptibility_to | 1.29686048 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.28905917 |
| 51 | MP0000716_abnormal_immune_system | 1.27075870 |
| 52 | MP0001845_abnormal_inflammatory_respons | 1.26027313 |
| 53 | MP0005076_abnormal_cell_differentiation | 1.24895811 |
| 54 | MP0005379_endocrine/exocrine_gland_phen | 1.20232464 |
| 55 | MP0000609_abnormal_liver_physiology | 1.19463526 |
| 56 | MP0002722_abnormal_immune_system | 1.18809563 |
| 57 | MP0003656_abnormal_erythrocyte_physiolo | 1.18494842 |
| 58 | MP0000703_abnormal_thymus_morphology | 1.17458007 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.15340908 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.15171700 |
| 61 | MP0005220_abnormal_exocrine_pancreas | 1.14795162 |
| 62 | MP0002163_abnormal_gland_morphology | 1.14100997 |
| 63 | MP0001853_heart_inflammation | 1.13027174 |
| 64 | MP0008058_abnormal_DNA_repair | 1.12867055 |
| 65 | MP0008469_abnormal_protein_level | 1.12332360 |
| 66 | MP0008057_abnormal_DNA_replication | 1.11918840 |
| 67 | MP0001944_abnormal_pancreas_morphology | 1.09739658 |
| 68 | MP0005671_abnormal_response_to | 1.09525724 |
| 69 | MP0002429_abnormal_blood_cell | 1.09374430 |
| 70 | MP0009785_altered_susceptibility_to | 1.08666361 |
| 71 | MP0008877_abnormal_DNA_methylation | 1.08532507 |
| 72 | MP0003786_premature_aging | 1.04847070 |
| 73 | MP0010155_abnormal_intestine_physiology | 1.03142050 |
| 74 | MP0002928_abnormal_bile_duct | 1.02995712 |
| 75 | MP0004510_myositis | 1.02781559 |
| 76 | MP0003787_abnormal_imprinting | 0.99249015 |
| 77 | MP0004947_skin_inflammation | 0.98689563 |
| 78 | MP0008995_early_reproductive_senescence | 0.98559383 |
| 79 | MP0009764_decreased_sensitivity_to | 0.98118979 |
| 80 | MP0000003_abnormal_adipose_tissue | 0.97889040 |
| 81 | MP0004858_abnormal_nervous_system | 0.97252729 |
| 82 | MP0003252_abnormal_bile_duct | 0.95647560 |
| 83 | MP0002970_abnormal_white_adipose | 0.92631692 |
| 84 | MP0000383_abnormal_hair_follicle | 0.92476657 |
| 85 | MP0006035_abnormal_mitochondrial_morpho | 0.92236032 |
| 86 | MP0009643_abnormal_urine_homeostasis | 0.90872648 |
| 87 | MP0002837_dystrophic_cardiac_calcinosis | 0.89935398 |
| 88 | MP0003866_abnormal_defecation | 0.88963360 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.88871819 |
| 90 | MP0002078_abnormal_glucose_homeostasis | 0.87978091 |
| 91 | MP0000598_abnormal_liver_morphology | 0.86888641 |
| 92 | MP0009115_abnormal_fat_cell | 0.86680332 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.86152763 |
| 94 | MP0005451_abnormal_body_composition | 0.85731402 |
| 95 | MP0002971_abnormal_brown_adipose | 0.85031630 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.84943775 |
| 97 | MP0002148_abnormal_hypersensitivity_rea | 0.84435514 |
| 98 | MP0005167_abnormal_blood-brain_barrier | 0.82771231 |
| 99 | MP0010678_abnormal_skin_adnexa | 0.78821775 |
| 100 | MP0001270_distended_abdomen | 0.78388679 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 4.79261313 |
| 2 | Abnormality of the fingertips (HP:0001211) | 3.97983034 |
| 3 | Hypoglycemic seizures (HP:0002173) | 3.81642881 |
| 4 | Hypoglycemic coma (HP:0001325) | 3.58271748 |
| 5 | Intestinal fistula (HP:0100819) | 3.55288414 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.42029217 |
| 7 | Sparse lateral eyebrow (HP:0005338) | 3.22138313 |
| 8 | Anal stenosis (HP:0002025) | 3.21427770 |
| 9 | Lip pit (HP:0100267) | 3.21365511 |
| 10 | Dysostosis multiplex (HP:0000943) | 3.17148018 |
| 11 | Thoracic kyphosis (HP:0002942) | 3.15662628 |
| 12 | Lower limb hyperreflexia (HP:0002395) | 3.03962165 |
| 13 | Ketoacidosis (HP:0001993) | 2.96702846 |
| 14 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.95836313 |
| 15 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.95836313 |
| 16 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.95836313 |
| 17 | Mucopolysacchariduria (HP:0008155) | 2.92987573 |
| 18 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.92987573 |
| 19 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.83633262 |
| 20 | Symptomatic seizures (HP:0011145) | 2.82967001 |
| 21 | Recurrent abscess formation (HP:0002722) | 2.81698012 |
| 22 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.78786225 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.73855114 |
| 24 | Myositis (HP:0100614) | 2.68828383 |
| 25 | Recurrent bacterial skin infections (HP:0005406) | 2.62177062 |
| 26 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.59618571 |
| 27 | Colitis (HP:0002583) | 2.58886609 |
| 28 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.56229489 |
| 29 | Recurrent fungal infections (HP:0002841) | 2.53304758 |
| 30 | Prominent metopic ridge (HP:0005487) | 2.50421463 |
| 31 | Eczematoid dermatitis (HP:0000976) | 2.49963414 |
| 32 | Hyperglycemia (HP:0003074) | 2.49832697 |
| 33 | Abnormality of T cell physiology (HP:0011840) | 2.47372587 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.47095773 |
| 35 | Abnormality of the thoracic spine (HP:0100711) | 2.45444182 |
| 36 | Increased CSF protein (HP:0002922) | 2.45435447 |
| 37 | Prolonged bleeding time (HP:0003010) | 2.43386559 |
| 38 | Ketosis (HP:0001946) | 2.42580600 |
| 39 | Inflammation of the large intestine (HP:0002037) | 2.39853888 |
| 40 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.39683204 |
| 41 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.39683204 |
| 42 | Gastrointestinal inflammation (HP:0004386) | 2.37781079 |
| 43 | Increased IgE level (HP:0003212) | 2.35780292 |
| 44 | Stomatitis (HP:0010280) | 2.33884785 |
| 45 | Ureteral stenosis (HP:0000071) | 2.32004330 |
| 46 | Late onset (HP:0003584) | 2.31926436 |
| 47 | Mediastinal lymphadenopathy (HP:0100721) | 2.28994190 |
| 48 | Urethral obstruction (HP:0000796) | 2.28895902 |
| 49 | Acute hepatic failure (HP:0006554) | 2.28139552 |
| 50 | Orchitis (HP:0100796) | 2.27784094 |
| 51 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.21206406 |
| 52 | Increased serum ferritin (HP:0003281) | 2.20983671 |
| 53 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.20934504 |
| 54 | Pustule (HP:0200039) | 2.20501295 |
| 55 | Dysmetric saccades (HP:0000641) | 2.19277819 |
| 56 | Meningitis (HP:0001287) | 2.16652980 |
| 57 | Fatigue (HP:0012378) | 2.12287296 |
| 58 | Abnormality of the metopic suture (HP:0005556) | 2.11774994 |
| 59 | Ureteral obstruction (HP:0006000) | 2.10929524 |
| 60 | Recurrent cutaneous fungal infections (HP:0011370) | 2.07362598 |
| 61 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.07362598 |
| 62 | Obstructive lung disease (HP:0006536) | 2.06978232 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.06978232 |
| 64 | Testicular atrophy (HP:0000029) | 2.05694762 |
| 65 | Hypochromic anemia (HP:0001931) | 2.03835991 |
| 66 | Abnormality of iron homeostasis (HP:0011031) | 1.99001129 |
| 67 | Abnormality of macrophages (HP:0004311) | 1.97511709 |
| 68 | Large for gestational age (HP:0001520) | 1.96569388 |
| 69 | Encephalitis (HP:0002383) | 1.95011011 |
| 70 | Testicular neoplasm (HP:0010788) | 1.90204396 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 1.89982512 |
| 72 | Optic neuritis (HP:0100653) | 1.89982512 |
| 73 | Episodic fever (HP:0001954) | 1.86723494 |
| 74 | Hyperthyroidism (HP:0000836) | 1.86288846 |
| 75 | Recurrent viral infections (HP:0004429) | 1.85921990 |
| 76 | Polydipsia (HP:0001959) | 1.84661194 |
| 77 | Abnormal drinking behavior (HP:0030082) | 1.84661194 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 1.84625760 |
| 79 | Septate vagina (HP:0001153) | 1.80731569 |
| 80 | Short 5th finger (HP:0009237) | 1.80072466 |
| 81 | Recurrent skin infections (HP:0001581) | 1.79722845 |
| 82 | Prolonged partial thromboplastin time (HP:0003645) | 1.79185882 |
| 83 | Nuclear cataract (HP:0100018) | 1.75279918 |
| 84 | Agammaglobulinemia (HP:0004432) | 1.75037598 |
| 85 | Vasculitis (HP:0002633) | 1.74948016 |
| 86 | Acute lymphatic leukemia (HP:0006721) | 1.73924124 |
| 87 | Asymmetry of the thorax (HP:0001555) | 1.73530970 |
| 88 | Abnormality of T cells (HP:0002843) | 1.72333975 |
| 89 | Viral hepatitis (HP:0006562) | 1.72030338 |
| 90 | Gingivitis (HP:0000230) | 1.71320310 |
| 91 | Abnormality of DNA repair (HP:0003254) | 1.70713038 |
| 92 | Generalized aminoaciduria (HP:0002909) | 1.69049334 |
| 93 | Progressive external ophthalmoplegia (HP:0000590) | 1.68585026 |
| 94 | Microvesicular hepatic steatosis (HP:0001414) | 1.68428965 |
| 95 | Abnormality of the peritoneum (HP:0002585) | 1.66987418 |
| 96 | Granulocytopenia (HP:0001913) | 1.66949096 |
| 97 | Abnormality of the periventricular white matter (HP:0002518) | 1.66596823 |
| 98 | Sandal gap (HP:0001852) | 1.66490283 |
| 99 | Disproportionate short-trunk short stature (HP:0003521) | 1.66463485 |
| 100 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.66204714 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 2.81919551 |
| 2 | TNK2 | 2.50127091 |
| 3 | PRPF4B | 2.49742596 |
| 4 | STK24 | 2.47210350 |
| 5 | MAP4K1 | 2.32641650 |
| 6 | MAP2K3 | 2.20090906 |
| 7 | MAP3K2 | 2.14945897 |
| 8 | CDK12 | 2.13655646 |
| 9 | EEF2K | 2.10854469 |
| 10 | WNK4 | 2.08702804 |
| 11 | FRK | 2.06728767 |
| 12 | PASK | 2.04598634 |
| 13 | TAOK3 | 2.01055594 |
| 14 | MAP3K3 | 1.94338204 |
| 15 | JAK3 | 1.87689082 |
| 16 | IRAK3 | 1.79847926 |
| 17 | IRAK4 | 1.77219355 |
| 18 | TRIB3 | 1.75748248 |
| 19 | MAP3K14 | 1.63621962 |
| 20 | TRPM7 | 1.59421223 |
| 21 | IRAK2 | 1.57891819 |
| 22 | RIPK4 | 1.57621004 |
| 23 | MAP3K7 | 1.50761937 |
| 24 | BMX | 1.48929235 |
| 25 | IKBKE | 1.44657234 |
| 26 | IKBKB | 1.38037432 |
| 27 | CAMK1G | 1.35922800 |
| 28 | IRAK1 | 1.33758572 |
| 29 | FES | 1.32329615 |
| 30 | KIT | 1.27970158 |
| 31 | TBK1 | 1.25645553 |
| 32 | SIK2 | 1.25593836 |
| 33 | BTK | 1.22232508 |
| 34 | MAP2K6 | 1.21813027 |
| 35 | CSF1R | 1.21213509 |
| 36 | CHUK | 1.16434188 |
| 37 | SIK1 | 1.14698629 |
| 38 | HIPK2 | 1.11273552 |
| 39 | TYK2 | 1.09817406 |
| 40 | BMPR2 | 1.08462990 |
| 41 | MAP3K1 | 1.08222674 |
| 42 | BLK | 1.06813179 |
| 43 | MAPK11 | 1.06242974 |
| 44 | MAP3K11 | 1.05938484 |
| 45 | HCK | 1.05375329 |
| 46 | GRK6 | 1.04996148 |
| 47 | DAPK2 | 1.04173032 |
| 48 | RPS6KC1 | 1.03371209 |
| 49 | RPS6KL1 | 1.03371209 |
| 50 | FGFR4 | 1.00542797 |
| 51 | WNK1 | 0.99141345 |
| 52 | CAMK1D | 0.98586039 |
| 53 | FGFR3 | 0.98220920 |
| 54 | MAP3K13 | 0.97174974 |
| 55 | SYK | 0.96383224 |
| 56 | RPS6KA6 | 0.96339224 |
| 57 | TEC | 0.95560887 |
| 58 | MARK2 | 0.95487191 |
| 59 | STK39 | 0.91463193 |
| 60 | SIK3 | 0.90008323 |
| 61 | TAOK1 | 0.88981809 |
| 62 | RPS6KB2 | 0.87964615 |
| 63 | ZAP70 | 0.83721573 |
| 64 | FGR | 0.82975616 |
| 65 | PINK1 | 0.81492856 |
| 66 | PDK1 | 0.81398277 |
| 67 | NLK | 0.78670185 |
| 68 | MAP4K2 | 0.77562775 |
| 69 | PRKAA2 | 0.71741341 |
| 70 | PDPK1 | 0.71672787 |
| 71 | MTOR | 0.69667803 |
| 72 | ITK | 0.67458830 |
| 73 | PRKAA1 | 0.66790016 |
| 74 | PTK2B | 0.66172621 |
| 75 | PKN2 | 0.65928255 |
| 76 | CAMKK2 | 0.65378430 |
| 77 | LCK | 0.64466354 |
| 78 | CAMK1 | 0.62703172 |
| 79 | MARK3 | 0.56352212 |
| 80 | CAMK4 | 0.56312117 |
| 81 | RET | 0.55376790 |
| 82 | YES1 | 0.55308963 |
| 83 | CAMKK1 | 0.54842814 |
| 84 | CDK4 | 0.54096650 |
| 85 | STK4 | 0.53394469 |
| 86 | TAOK2 | 0.53363269 |
| 87 | CDC42BPA | 0.53167628 |
| 88 | PIM1 | 0.52429662 |
| 89 | CSK | 0.52079407 |
| 90 | RPS6KA2 | 0.51195815 |
| 91 | PRKD2 | 0.50770408 |
| 92 | LYN | 0.50569340 |
| 93 | MAP3K10 | 0.49205567 |
| 94 | TRIM28 | 0.45823966 |
| 95 | JAK1 | 0.44640542 |
| 96 | TLK1 | 0.44348798 |
| 97 | MATK | 0.44208280 |
| 98 | CDK9 | 0.42719493 |
| 99 | PRKCQ | 0.41240243 |
| 100 | SGK3 | 0.40907303 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.03099412 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 3.78355344 |
| 3 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.25457364 |
| 4 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.23237484 |
| 5 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.19462488 |
| 6 | ABC transporters_Homo sapiens_hsa02010 | 1.94195404 |
| 7 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.80104930 |
| 8 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.79692812 |
| 9 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.78781707 |
| 10 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.77369926 |
| 11 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.77171809 |
| 12 | Leishmaniasis_Homo sapiens_hsa05140 | 1.72286394 |
| 13 | Lysine degradation_Homo sapiens_hsa00310 | 1.55079960 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.52651202 |
| 15 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.52114442 |
| 16 | Insulin resistance_Homo sapiens_hsa04931 | 1.47730318 |
| 17 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.40740443 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.40511002 |
| 19 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.40012915 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39602495 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.39428851 |
| 22 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.35703025 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.29235694 |
| 24 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.28694795 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.26721237 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.24945427 |
| 27 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.20609110 |
| 28 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.19337656 |
| 29 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19103537 |
| 30 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.18150786 |
| 31 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.18018029 |
| 32 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.16760205 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.15927789 |
| 34 | FoxO signaling pathway_Homo sapiens_hsa04068 | 1.14270271 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.12190208 |
| 36 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.08401765 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.08359168 |
| 38 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.06875416 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.06585591 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04290813 |
| 41 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.03103804 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.00448995 |
| 43 | Influenza A_Homo sapiens_hsa05164 | 0.99958052 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.99922096 |
| 45 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99849161 |
| 46 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.99191196 |
| 47 | Measles_Homo sapiens_hsa05162 | 0.94307355 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.94016068 |
| 49 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.93904155 |
| 50 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.92291375 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91908391 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.91012479 |
| 53 | Pertussis_Homo sapiens_hsa05133 | 0.89107243 |
| 54 | Hepatitis C_Homo sapiens_hsa05160 | 0.88060038 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.87375915 |
| 56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.85207394 |
| 57 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82632898 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81259720 |
| 59 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.81024691 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.80111374 |
| 61 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.79285689 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.79160254 |
| 63 | Insulin secretion_Homo sapiens_hsa04911 | 0.79083538 |
| 64 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78669951 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.76890939 |
| 66 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.76028455 |
| 67 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.75275885 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.74323179 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.74287924 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.74117793 |
| 71 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72133475 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71411085 |
| 73 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.71237223 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71066015 |
| 75 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.69354027 |
| 76 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66342320 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.65523358 |
| 78 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.65159980 |
| 79 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.64533709 |
| 80 | Shigellosis_Homo sapiens_hsa05131 | 0.62596330 |
| 81 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.60844902 |
| 82 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.59637708 |
| 83 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.59329937 |
| 84 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58252067 |
| 85 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57894835 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.57540310 |
| 87 | Asthma_Homo sapiens_hsa05310 | 0.55280337 |
| 88 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54771953 |
| 89 | Platelet activation_Homo sapiens_hsa04611 | 0.54465655 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.48201141 |
| 91 | Prostate cancer_Homo sapiens_hsa05215 | 0.47357874 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.46936472 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.46802963 |
| 94 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.46648058 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46633359 |
| 96 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44493305 |
| 97 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.42591629 |
| 98 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41833734 |
| 99 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41525461 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.40529685 |

